Plate Nº 44 · recorded November 15, 2026
Neuroscience & MindReported finding
One Patient, One Procedure: Right Amygdala Tied to PTSD
A single-patient case study in Nature Communications shows inactivating part of the right amygdala immediately reduced threat bias and cut severe PTSD symptoms from 50 to 21 within two months.
By Elena Vasquez5 min read929 words
In brief
- Ablating 47% of the right amygdala cut a patient's PTSD score from 50 to 21 in two months, below the diagnostic cutoff of 31-33.
- The drop in trauma symptoms occurred while seizure rates stayed unchanged at roughly 10 per month.
- Twenty minutes after ablation, the patient stopped over-labeling ambiguous faces as fearful.
- The study, published in Nature Communications, tracked brain signals and emotion perception before and after the awake procedure.
- Senior author Jon T. Willie cautions the evidence comes from one patient and amygdala ablation is not a validated PTSD therapy.

A 41-year-old man's PTSD score fell from 50 — severe — to 21 in two months after surgeons inactivated 47 percent of his right amygdala, a small almond-shaped cluster of neurons deep behind the temple. The score landed well below the diagnostic cutoff of 31 to 33, and the relief came without talk therapy or PTSD medications. Published in Nature Communications, the case study offers rare causal evidence that the right amygdala helps sustain PTSD symptoms and the threat-focused thinking that drives them.
The patient had drug-resistant temporal lobe epilepsy and chronic, severe PTSD stemming from adolescent trauma. His epilepsy was the reason for surgery; the psychiatric outcome was a secondary question the research team tracked closely.
Why the amygdala matters in PTSD
PTSD can develop after severe trauma and brings intrusive memories, avoidance of reminders, negative mood shifts and persistent jumpiness. A core feature is negative interpretation bias: reading neutral or ambiguous cues, like an unreadable face, as threatening. That keeps fear responses running hot.
Brain scans consistently show heightened amygdala reactivity in people with PTSD. But imaging only shows correlation, not cause. It can't tell whether abnormal amygdala activity drives the bias or merely travels alongside it.
Senior author Jon T. Willie, chief of functional and epilepsy surgery at the University of Texas at Austin's Dell Medical School, told PsyPost the field faces "a lack of validated biomarkers of intracranial activity that localize and monitor abnormal cognitive activity in PTSD," plus a "lack of understanding of lateralized functions of right versus left amygdala in PTSD."
A 2020 case series Willie co-authored found laser ablation of the right amygdala and adjacent hippocampus eased PTSD symptoms — but couldn't separate the amygdala's role from seizure control. The new study, led by first author Tao Xie with co-senior author Peter Brunner, solved that problem: this patient's right-amygdala ablation came two months before his hippocampus surgery.
How doctors mapped and silenced the tissue
The team used stereoelectroencephalography-guided radiofrequency ablation. Thin wire electrodes implanted deep in the brain record electrical activity and locate seizure sources. High-frequency current then heats selected contacts to roughly 58 to 60 degrees Celsius, permanently inactivating a three- to seven-millimeter zone while the patient stays awake.
Doctors placed seven electrode contacts in his right amygdala and three in his left. They compared him against 16 epilepsy patients without PTSD — seven men, nine women, average age 37 — monitored at the same hospital.
Before ablation, he completed 252 trials of a facial emotion task; controls did about 260 on average. Participants saw faces for one second, morphed from fully happy to fully fearful, with 50 percent marking an ambiguous expression, then labeled each face and rated their confidence.
What changed immediately after ablation?
Before the procedure, the patient judged ambiguous 50-percent faces as fearful far more often than controls — a statistically significant gap versus the male controls but not the female controls. His right lateral amygdala recordings showed late-phase brain waves (350 to 650 milliseconds after each face) that exceeded the 90th percentile of controls.
Pre-ablation stimulation also revealed a left-right split. Mild 1.5 to 2.0 milliampere currents in three right-amygdala subregions evoked tingling chills and euphoria. Left-amygdala stimulation produced nothing until 3.0 milliamperes, which triggered a pleasant childhood memory.
That afternoon, doctors ablated tissue around five right-amygdala contacts, sparing more than 99.9 percent of the right hippocampus. Twenty minutes later, across 336 trials, he labeled ambiguous and moderately fearful faces as fearful much less often, matching controls on intermediate expressions. His reaction times slowed from 0.7 to 1.1 seconds, and the late-phase electrical gap between fearful and happy faces vanished across the right amygdala. A new distinction emerged in his intact left amygdala, which the authors suggest may reflect slower, more deliberate emotional evaluation.
Relief without seizure control
His seizure rate held steady at roughly 10 per month for two months, dropping below one per month only after the later hippocampus surgery. That stability means the PTSD relief wasn't a byproduct of seizure control.
"The remarkable result was evidence of immediate widespread changes in behavior, brain dynamics, and PTSD benefit without dependency on other traditional therapies such as medications or cognitive behavioral therapy," Willie said. Gains spanned intrusive memories, avoidance, negative mood and hyperarousal, with milder drops in anxiety and depression.
"The novelty of the study is that this is the first clear demonstration of a specific causal role for the right amygdala in maintaining PTSD," Willie said, noting it is "an early feasibility study that could lead to future larger studies."
The caveats
One patient, years of epilepsy and antiseizure medications — his neural wiring may not represent most people with PTSD. Awake surgery can't be blinded, so expectation or task familiarity may have influenced results. The slowed judgments and shifted ratings at both emotional extremes hint the ablation may blunt overall emotional calibration, not threat bias alone. Durability beyond two months is unknown, though he still reported relief a year later.
"Readers should be cautioned that amygdala ablation has not been sufficiently studied to offer this widely as a therapy for PTSD," Willie emphasized. Larger controlled trials, and reversible techniques like focused ultrasound or stimulation, must come first. His team now studies how the amygdala recognizes safety versus threat in epilepsy patients undergoing brain monitoring.
Bottom line: silencing one overactive brain region briefly rewired a man's threat perception and eased severe PTSD — a clue, not a cure.
via psypost.org (Source)
More from Elena Vasquez
Show full bio
Correspondent covering money, funding and market shifts around general science news at SciBeat.
434 articles
Nearby plates
- Amygdala activity predicts which images become lasting memories
- The Brain's Fear Center Doubles as a Save Button for Memory
- Mouse Study Maps a Brain Circuit That Tunes Stress Responses
- Nearly 1 in 3 Ukrainian Civilians Shows Signs of PTSD or Complex PTSD
- Fear May Blur Danger and Safety in the Brain, Not Sharpen It